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Current diagnoses of schizophrenia (SZ) and bipolar disorder (BD) are classified by 
phenomenological principles and clinical descriptions. The boundaries of the disorders are 
merging with accumulating shared genetic and brain mechanisms being uncovered. Imaging 
genetics is a useful tool to understand the impact of genetic variations on the brain. It also 
enables capturing the behavioral implication of those genes and associated brain alterations. 
This study aimed to reveal the associations among sets of genetic variations, structural 
brain abnormalities, and clinical symptom profiles shared in schizophrenia and bipolar disorders 
by imaging genetics and multivariate approaches. First, we mapped the symptom profiles onto 
brain patterns. Distinct structural brain patterns guided with symptom profiles represented by 
positive and negative syndrome scale (PANSS), through parallel independent component 
analysis (pICA) were extracted. Brain patterns related to positive symptoms, mood, and apathy 
were discovered in SZ and BD. Second, we investigated the relationships of symptoms and brain 
patterns regardless of diagnostic categories by projecting each disorder’s structural brain and 
PANSS patterns into the other disorder group (e.g., projecting patterns from schizophrenia to 
bipolar and vice versa) to reassess the associations. The projected brain patterns showed 
associations with broad symptoms rather than the original PANSS patterns. Finally, we explored 
the potential shared genetic mechanisms behind symptom-brain patterns by investigating the 
effect of polygenic risk scores (PRS) from the Psychiatric Genomics Consortium (PGC). Both 
SZ and BD PRS were significantly associated with the positive symptom-related brain patterns 
in SZ. Higher genetic risks contributed to more severe gray matter concentration (GMC) 
reductions in the temporal regions of SZ patients, and it may lead to worse positive symptoms. 
Correspondingly, in the BD, both SZ and BD PRS were significantly associated with the mood 
symptom-related brain patterns. Higher risks contributed to more severe gray matter 
concentration (GMC) reductions in the frontal-temporal-parietal circuits with worse mood 
symptoms. The polygenic effects behind the apathy component may be subtle. The results helped 
improve the understanding of categories of psychotic disorders starting from schizophrenia and 
bipolar disorder. It may essentially contribute to the more precise diagnosis and treatment for 
heterogeneous populations with psychosis. 
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1 INTRODUCTION AND LITERATURE REVIEW 
1.1 Purpose of the Study  
The current categories of psychiatric disorders are mainly based on phenomenological 
observation and clinical descriptions (Feighner et al., 1972; Jiang, King, & Turner, 2019; Lawrie, 
O'Donovan, Saks, Burns, & Lieberman, 2016b). Though these descriptions are reliable, they are 
not established on precise pathological bases, thus facing difficulties in clinical heterogeneities 
(Feighner et al., 1972; Robins & Guze, 1970). Additionally, similar psychotic symptoms 
aggregate in different disorders and families. Underlying the aggregation, shared biological 
mechanisms, including genetics and neural circuitry, are found (Bipolar Disorder Schizophrenia 
Working Group of the Psychiatric Genomics Consortium, 2018; Cross-Disorder Group of the 
Psychiatric Genomics et al., 2013; Noordermeer et al., 2017; van Haren, Bakker, & Kahn, 2008). 
These findings suggest that the boundaries of psychiatric disorders are merging (Lawrie, 
O'Donovan, Saks, Burns, & Lieberman, 2016a; Pearlson, Clementz, Sweeney, Keshavan, & 
Tamminga, 2016). 
In current research attempts, schizophrenia (SZ) and bipolar disorder (BD) are often 
studied together to elucidate this cross diagnostic issue due to their clinical similarities, high 
genetic correlation, and partially shared brain structural deficits (Andreassen et al., 2013; Bipolar 
Disorder Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2018; Stahl et 
al., 2019) SZ patients generally show smaller brain volumes, overall gray matter reductions in 
fronto-temporal, thalamo-cortical, subcortical-limbic circuits, and enlargement of ventricles 
(partially shared by BD) (Palaniyappan et al., 2015). These brain alterations induced in part by 
genetic variations (van Haren et al., 2008) are bridging the gap between gene and the 
intermediate phenotype (Arslan, 2015; Gottesman & Gould, 2003), and even clinical symptoms 
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of disorders (Nenadic, Gaser, & Sauer, 2012) (see Figure 1). With the above so-called imaging 
genetics method (Hashimoto et al., 2015; Meyer-Lindenberg & Weinberger, 2006; Thompson, 
Ge, Glahn, Jahanshad, & Nichols, 2013; Turner et al., 2006), some exploratory studies have been 
done to subdivide SZ and BD into different diagnostic groups regardless of their original 
diagnosis (Clementz et al., 2016; Ivleva et al., 2016; Meda et al., 2015; Tandon et al., 2016). 
However, further investigation to link these overlapped imaging and genetic variations with the 
core symptom profiles is needed before moving forward into clinical practice (Tamminga et al., 
2013). To answer how exactly do potential imaging and genetic findings explain the clinical 
symptom profiles and ensure stability, we will review related literature and try to discuss 
possible methods in the following parts. The followings were partially published in author’s 
previous review article (Jiang et al., 2019). 
 
 
Figure 1 The research strategy of imaging genetics (Jiang et al., 2019) 
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1.2 Genetic overlap between Schizophrenia and Bipolar Disorder  
Besides the clinical observation of similarity in both disorders' symptoms and prognosis, 
growing evidence from genetic and imaging studies confirms this overlap (Cross-Disorder Group 
of the Psychiatric Genomics, 2013). Genes contribute greatly to the etiology of SZ and BD. The 
heritability of SZ was around 80%, while in BD, it is estimated to be over 70% through meta-
analysis twin studies (Lichtenstein et al., 2009; Sullivan, Kendler, & Neale, 2003).  Additionally, 
an overall genetic correlation of 0.68 between SZ and BD has been demonstrated based on 
common variants (Cross-Disorder Group of the Psychiatric Genomics, 2013). 
The Val158Met single polymorphism (SNP) of catechol-O-methyltransferase (COMT), 
the Val66Met SNP of brain-derived neurotrophic factor (BDNF), and the Ser704Cys SNP of 
disrupted-in-SZ 1 (DISC1) are the most well-known risk genes identified by candidate gene 
analysis (Hashimoto et al., 2015). In contrast, the first few reports of genome-wide association 
study (GWAS)  demonstrated several loci associated with SZ, including Zinc finger protein 
804A (ZNF804A), neurogranin (NRGN), and the major histocompatibility complex (MHC) 
region. GWAS studies with increased sample size discovered more SZ related loci, and some of 
these loci were shared by BD and other psychiatric disorders.(O'Donovan et al., 2008; Schwab & 
Wildenauer, 2013). ZNF804A is the first discovered marker that may increase risk for both SZ 
and BD, and meta-analysis has also supported its role (Williams et al., 2011). The combined SZ 
and BD GWAS study from the Psychiatric Genomics Consortium (PGC) has identified Calcium 
Voltage-Gated Channel Subunit Alpha1 C (CACNA1C), Ankyrin-3(ANK3), and Inter-Alpha-
Trypsin Inhibitor Heavy Chain 3-4 (ITIH3-ITIH4) as a risk for both disorders (Schizophrenia 
Psychiatric Genome-Wide Association Study, 2011; Sullivan, Daly, & O'Donovan, 2012). Later, 
introducing a pleiotropy-informed conditional false discovery rate, 14 loci were associated with 
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both disorders, and CACNA1C and ITIH4 were identified again (Andreassen et al., 2013). The 
PGC's diagnostic specificity of 5 disorders analyses has also shown 5'-nucleotidase, cytosolic II 
(NT5C2), and coiled-coil domain containing 68 (CCDC68) are associated with both disorders 
(Cross-Disorder Group of the Psychiatric Genomics, 2013). The combined GWAS studies will 
continue to reveal more critical loci, but the functional implication and role of these distinct 
genes in SZ and BD will need further investigation. 
In addition to candidate gene analysis, polygenetic methods combine a large number of 
loci, allowing the overlap between disorders to be broadly assessed (Cross-Disorder Group of the 
Psychiatric Genomics, 2013) As mentioned above, a genetic correlation around 0.68 blurs the 
distinction across categories again and indicates a broad genetic mechanism for SZ and BD.  
1.3 Structural Brains alterations in Schizophrenia and Bipolar Disorder  
1.3.1 Structural Brain Alteration in SZ 
Anatomical changes in fronto-temporal, thalamo-cortical, subcortical-limbic circuits, 
enlargement of ventricles, and widespread white matter fibers abnormalities are found in 
structural brain studies in SZ; still, heterogeneity in brain abnormality patterns is shown across 
different studies (Dazzan et al., 2015). With the growing sample size and collaboration through 
different sites, many large meta-analyses have provided new information. The ENIGMA SZ 
working group’s meta-analysis of subcortical regions across several thousand subjects reported 
the consistent findings of the smaller hippocampus, amygdala, thalamus, accumbens, and 
intracranial volumes, but larger pallidum and lateral ventricles (van Erp et al., 2016). The 
putamen and caudate volume effects were not reliable across different populations and studies 
even with this sample size, indicating the possibility of clinical heterogeneity affecting those 
regions (van Erp et al., 2016). In addition, widespread cortical thinning and smaller surface area 
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with the strongest effect in frontal and temporal regions were identified in SZ again in an 
ENIGMA SZ study (van Erp et al., 2018). 
Functional imaging studies yield comparable results with structural studies. The reduced 
activation in the prefrontal cortex, superior temporal gyrus, thalamus, frontal lobe, and parietal 
lobe has been reported in either resting state or task fMRI  (Cao, Dixson, Meyer-Lindenberg, & 
Tost, 2016). Besides all these regions of hypoactivity, hyperactivity has also been reported in the 
hippocampus and putamen (Cao et al., 2016). Besides, functional connectivity, network analysis, 
and graph theory application to functional imaging data form an even larger neuroanatomical 
map and will only be discussed in the following sections when studied using an imaging genetic 
method and with relatively consistent functional implications. 
1.3.2 Structural Brain Alteration in BD 
The anatomical changes in BD are milder and less consistent than SZ (Hibar et al., 2018; 
Hibar et al., 2016; van Erp et al., 2016; van Erp et al., 2018). Various meta-analyses of structural 
MRI studies have been carried out in BD and healthy controls. The only consistent findings 
based on previous literature were the enlargement of the right lateral ventricular (Kempton, 
Geddes, Ettinger, Williams, & Grasby, 2008; McDonald et al., 2004). Other studies may indicate 
dorsolateral prefrontal cortex (Dickstein et al., 2005), ventrolateral prefrontal cortex (Blumberg 
et al., 2006), superior temporal gyrus (Elvsashagen et al., 2013; Hegarty et al., 2012; Lyoo et al., 
2006), the anterior cingulate (Fornito et al., 2008; Fornito et al., 2009) and subcortical region 
including amygdala with the thalamus (McDonald et al., 2004) are potentially affected in BD and 
controls. The ENIGMA BD working group identified consistent and robust grey matter deficits 
in subcortical regions, including the hippocampus, thalamus, and enlarged lateral ventricles 
(Hibar et al., 2016). In cortical regions, cortical thinning was found in frontal, temporal, and 
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parietal regions e.g. pars opercularis, left fusiform gyrus and left rostral middle frontal cortex 
(Hibar et al., 2018). The functional findings of BD can be less consistent than the structural 
findings, though they reflect similar regions. The most commonly detected hypo/hyper-activation 
in prefrontal-frontal-limbic circuits indicated disrupted emotional regulation in BD patients 
(Chen, Suckling, Lennox, Ooi, & Bullmore, 2011; Strakowski, Delbello, & Adler, 2005; 
Townsend & Altshuler, 2012). 
1.3.3 Potential Brain Alterations Shared by SZ and BD 
Many of the above regions have been identified as structural or functional commonalities 
among multiple diagnostic categories, including SZ and BD (Isobe et al., 2016; Schwarz, Tost, & 
Meyer-Lindenberg, 2016). SZ and BD both have deficits in the frontal-temporal-parietal circuit 
(Hibar et al., 2018; van Erp et al., 2018), prefrontal-striatal-thalamic-cerebellar circuit (Soh et al., 
2015), default mode network (Soh et al., 2015; Wang et al., 2015), insula (Maggioni, Bellani, 
Altamura, & Brambilla, 2016; Selvaraj et al., 2012), anterior cingulate cortex (Arnone et al., 
2009; Ellison-Wright & Bullmore, 2010), and other numerous brain regions (Yu et al., 2010). 
In addition, starting from the same point as genetics, imaging research efforts are trying 
to redraw the boundaries between psychotic disorders with shared imaging features. From 
Bipolar-SZ Network on Intermediate Phenotypes (B-SNIP) Consortium, Clementz et al. applied 
neurobiological measures among SZ, BD, and SAD ,their first-degree relatives, and unrelated 
controls, and tried to regroup them into “biotypes” rather than DSM catalogs (Clementz et al., 
2016), using a wide selection of psychotic biomarkers and functional brain activity measures.  
Clementz et al. then identified three “biotypes” which were also found to be more heritable than 
their original DSM diagnoses. Sensorimotor reactivity and cognitive control performance 
distinguish three biotypes: Biotype 1 patients showed serious impairment across sensorimotor 
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reactivity and cognitive control. Biotype 2 patients show only cognitive control deficits,, and 
biotype 3 patients seem to be the mildest in cognitive symptoms. The B-SNIP group has also 
been trying to find other factors contributing to its biotyping; one attempt is to use the low-
frequency fluctuations (ALFF/fALFF) across the SZ, BD, and SAD from a large family study 
(Meda et al., 2015). More recently, gray matter density was checked in these three biotypes, and 
the density loss followed the same order as cognitive decline: biotype 1 showed whole-brain gray 
matter density loss, while type 2 showed largely overlapping results with type 1, and the largest 
effects were found in fronto-temporal circuits, parietal cortex, and cerebellum. The findings were 
much more localized and of less magnitude for type 1. Type 3 only showed small reductions in 
frontal, cingulate, and temporal regions despite their similar DSM diagnoses (Ivleva et al., 2016). 
In a larger perspective, both highlighted by ENIGMA and B-SNIP studies, the most robust and 
stable GM alterations shared between SZ and BD may spread throughout the whole brain with a 
strong emphasis on the frontal-temporal-parietal circuits. In addition, this circuit plays an 
important role in shared anatomical bases for potential biotypes between SZ and BD. These 
findings help mark the targets for the phenotypic and genetic implications behind common brain 
alterations in SZ and BD. 
1.4 Imaging Genetics of Psychotic Symptoms and Cognition 
The imaging genetic studies incorporating a complete pathway from genes and structural 
brain alterations to clinical symptoms are very limited (Hashimoto et al., 2015; Sagar & 
Pattanayak, 2017; Shahab et al., 2018; Strik, Stegmayer, Walther, & Dierks, 2017). Researchers 
have been trying to map psychotic symptoms of disorders like SZ and BD onto brain structure 
and function for decades (Strik et al., 2017). It is generally understood that symptoms including 
thought disorders (Cavelti, Kircher, Nagels, Strik, & Homan, 2018; Kaplan et al., 1993; Liddle et 
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al., 1992; Sabri et al., 1997) and auditory verbal hallucinations (Hare et al., 2017; Hare et al., 
2018; Kompus, Westerhausen, & Hugdahl, 2011; Stegmayer et al., 2017) can be mapped to 
semantic regions, affective and paranoid syndromes to limbic regions (Garety & Freeman, 2013; 
Kapur, 2003; Lebow & Chen, 2016; Ramirez, Moscarello, LeDoux, & Sears, 2015) and motor 
symptoms to the executive domain (Kendler, 2016; Peralta & Cuesta, 2017; van Harten, Walther, 
Kent, Sponheim, & Mittal, 2017). However, these results can be quite broad, and lack 
replications (Insel et al., 2010; Strik et al., 2017). 
Some imaging genetic studies in cognition may add to our knowledge based on the 
aggregate pathway of single cognitive domains and shared risk genes between SZ and BD. 
Working memory deficit is a fundamental and critical characteristic in SZ and BD. The most 
well studied intermediate imaging phenotype was the connection abnormalities between 
dorsolateral prefrontal cortex and hippocampus. Among the shared risk genes, ZNF804A 
(Esslinger et al., 2009; Paulus et al., 2013; Rasetti et al., 2011) and CACNA1C (Paulus et al., 
2014) have been associated with the prefrontal cortex and hippocampus connection alteration. In 
healthy subjects, the risk allele of ZNF804A was associated with increased connectivity. COMT 
(Tan et al., 2012), Regulator of G protein signaling 4 (RGS4) (Buckholtz et al., 2007), and 
COMT X glutamate metabotropic receptor 3 (GRM3) epistasis are connected to prefrontal 
cortex-parietal coupling in healthy subjects. For episodic and long-term memory, which is also 
often disturbed in SZ and BD, possible intermediate imaging phenotypes included decreased 
coupling of the hippocampus-parietal cortex, hippocampus, ventrolateral prefrontal cortex, and 
bilateral hippocampus (Bearden, Woogen, & Glahn, 2010; Guo, Ragland, & Carter, 2019; 
Shinozaki & Potash, 2014). However, the genetic association within this thread is elusive (Cao et 
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al., 2016). CACNA1C (Erk et al., 2010) and NRGN (Krug et al., 2013) might be involved in 
these memory processes as well. 
There are several other cognitive functions often impaired both in SZ and BD. Essential 
risk genes including NOS1, CACNA1C, and ZNF804A affected attentions deficits through 
alterations in the prefrontal cortex and inferior frontal gyrus (Zhang et al., 2015), inferior parietal 
lobule and medial frontal gyrus (Thimm et al., 2011), anterior cingulate cortex (Thurin et al., 
2013), and bilateral hippocampus (Bigos et al., 2010). In emotion-processing, ZNF804A 
(Esslinger et al., 2009), DRD2 (Blasi et al., 2009), COMT (Drabant et al., 2006), and MIR137 
(Mothersill et al., 2014) have been proved for their roles in affecting the amygdala, anterior 
cingulated, and prefrontal cortex which was directly connected the various stages of emotion 
processing. The reduced theory of mind capabilities tends to hinder SZ and BD patients from 
understanding themselves and others' mental states. ZNF804A risk alleles along with alterations 
in the prefrontal cortex, parietal cortex, and temporal-parietal junction were found critical in such 
social information processes (Mohnke et al., 2014; Walter et al., 2011). 
In summary, current imaging genetic studies with behavioral implications among SZ and 
BD are mostly limited to functional brain measures (Jiang et al., 2019). In addition, most of these 
trials were not directly carried out in patients with SZ and BD (Cao et al., 2016). Inevitably, 
besides cognitive impairment, clinical symptoms are even more critical for the diagnostic issue 
and future work of disorder boundaries. Finally, candidate gene analyses reveal relatively small 
effect sizes and explain limited brain alterations (Hibar et al., 2015). In contrast, this study 
focuses on extracting structural brain deficits associated with clinical symptom profiles to 
overcome such limitations. The common allele suggested by SZ and BD GWAS study will be 
collected to weight the polygenic risk on the extracted brain deficits in either diagnostic group. 
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Thus, insight can be provided for possible shared imaging genetic mechanisms behind SZ/BD 
symptoms. 
1.5 Multivariate Analysis and Data Projection 
As discussed above, though candidate gene analyses reveal some genetic effects on brain 
alterations, the effect size and consistency across different studies are limited. Combining genetic 
risk as a polygenic risk score may help resolve this issue (Bogdan et al., 2017; Euesden, Lewis, 
& O'Reilly, 2015; Hashimoto et al., 2015). However, imaging phenotypes can be another 
essential source resulting in such inconsistence (Winkler et al., 2010). The genetic loci or SNPs 
may have potential effects on multiple brain regions rather than a single region. Previously 
identified anatomical atlas and the region of interest studies based on a detailed atlas may fail to 
capture the complete genetic influence (Desikan et al., 2006). In addition, brain regions 
themselves are not independent, and they are likely to demonstrate some covariation (Jiang et al., 
2019; Mennigen et al., 2019).  
Multivariate analysis such as independent component analysis (ICA) or source-based 
morphometry (SBM) is useful in constructing such brain phenotypes considering their 
covariance (Xu, Groth, Pearlson, Schretlen, & Calhoun, 2009). The multivariate analysis 
produces distinct spatial brain structural circuits that covary in the data. All brain voxels and the 
relationship among them are taken into consideration simultaneously. Multivariate analysis has 
proved its usefulness and reproducibility in the decomposing structural brain (Gupta et al., 2015) 
and its association with heritability (Sprooten et al., 2015; Turner et al., 2012) in psychiatric 
disorders.  
Similarly, the mapping of psychiatric symptomatology onto specific brain structural 
alterations has yielded inconsistent findings. Most previous studies have calculated associations 
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between symptoms and structural brain measures using predefined brain regions based on atlas 
parcellations or voxels, and total or factor scores from assessment scales on the other hand. Even 
though these approaches are informative, they might lack sensitivity to detect alterations 
associated with specific symptoms or clusters of symptoms. In one step further than SBM/ICA, 
one approach to overcome these shortcomings is to apply parallel independent component 
analysis (pICA), which identifies patterns of alterations within two or more modalities 
simultaneously (Calhoun & Sui, 2016; Liu et al., 2009; Pearlson, Liu, & Calhoun, 2015). The 
extension to ICA/SBM algorithm, pICA, performs individual ICA on multiple data modalities, 
‘in parallel’,  maximizing independence within each modality while optimizing the correlation of 
independent components between the data modalities. As a result of this type of analysis, 
correlation coefficients between the two modalities' independent components are estimated. 
Individuals' loading coefficients for each independent component can then be used to interrogate 
group differences further. A recent study employing pICA on functional connectivity measures 
of the default mode network (DMN) and genetic data found that genes regulating 
neurodevelopmental processes are associated with functional hypoconnectivity of the DMN in 
patients with schizophrenia (Meda et al., 2015). Applying pICA will provide meaningful insights 
into the etiology of psychiatric disorders, encouraging further multimodal investigations.  
In addition to multivariate analysis in a single data, projection of multivariate findings 
can again enhance the stability and contribute to the cross disorder issue. In new data (e.g. 
another disorder), projection helps achieve the loading coefficients corresponding to the original 
components such as brain patterns, gene/SNP sets, and clinical profiles. It makes it possible to 
reassess the association between projected patterns in the new data (Chen et al., 2019). In this 
way, the mapping of symptomatology onto the brain in SZ can be projected into BD patients, and 
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it will help to reveal whether association remains valid between psychiatric symptom profile and 
brain alterations despite the diagnostic categories. 
In summary, multivariate analysis helps to construct the symptom profiles, structural 
brain patterns, and genetic risk covarying through the data. Thus, it will reduce the bias of 
selecting behavioral and brain phenotypes and maximize the modalities' potential. The projection 
of these multivariate findings helps validate discovered associations across different disorders 
with the potential shared mechanism. Also, polygenic methods rather than single variation 
enhance the capturing of genetic effects in a more realistic background. Therefore, to answer 
how exactly do potential imaging and genetic findings explain the clinical symptom profiles and 
ensure stability, we extracted the brain structural effects behind clinical profiles from both SZ 
and BD through pICA. Additionally, we examined whether these brain alterations were shared 
by SZ and BD or specific to the original diagnostic groups. Finally, we explored the polygenic 
factors that modify brain patterns. Thus, we presented potential pathways from genes to brain to 




2 AIM 1: MAP STRUCTURAL ALTERATIONS ONTO PSYCHOTIC SYMPTOM 
PROFILE(S) IN SZ AND BD  
 
2.1 Aim and hypothesis 
In this study, the first aim was to map structural alterations of brains onto the psychotic 
symptom profile(s) in SZ and BD. The symptom profiles were represented and described by the 
Positive and Negative Symptom Scale (PANSS). The correlations between loading coefficients 
of brain and PANSS components extracted by pICA were tested, and the patterns of brain and 
profiles of symptoms were examined. We hypothesized that, given the different symptom 
patterns in the different disorders, the symptoms profiles represented by the PANSS will extract 
distinct brain structural components in both SZ and BD. These analyses have been published in 
part in author’s previous publications (Jiang et al., 2020; Mennigen et al., 2019).  
2.2 Methods 
2.2.1 Participants 
For the whole project, data were pooled from seven major studies: TOP (Thematic 
Organized Psychosis research; Oslo, Norway) (Athanasiu et al., 2010), FBIRN 3 (Functional 
imaging Biomedical Information Research Network, multiple sites in the USA) (Potkin et al., 
2009; Wible et al., 2009), COBRE (Center of Biomedical Research Excellence, Albuquerque, 
NM, USA) (Aine et al., 2017; Gupta et al., 2015), B-SNIP (Bipolar and Schizophrenia Network 
for Intermediate Phenotypes, multiple sites in the USA) (Meda et al., 2014), MCIC (MIND 
Clinical Imaging Consortium, Albuquerque, NM, USA ) (Gollub et al., 2013), and HUBIN 
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(Human Brain Informatics, Stockholm, Sweden.) (Nesvag et al., 2008). Data were collected 
under the approval of local institutional review boards, and all participants provided informed 
consent. All studies provided structural MRI data as well as PANSS item scores. In total, data 
were obtained from 1065 patients with a diagnosis of SZ, 268 patients with a diagnosis of BD, 
and 1011 NC, as confirmed by the Structured Clinical Interview for Diagnosis (SCID) for DSM-
IV or DSM-IVTR conducted at each study site (First, 2004). All studies provided information on 
age at the time of the scan, sex, duration of illness, and medication status (in varying details) for 
each participant. Scanning information is included in table 1. 
Table 1 Scanning and site information for each dataset 
 
Study Size Sites Scanner (T) Sequence Voxel size (mm) Orientation 
FBIRN3 356 8 Siemens Tim Trio (3) MPRAGE 1.1 x 0.9 x 1.2 Sagittal 
TOP 414 1 Siemens (1.5) MPRAGE 1.33 x 0.94 x 1 Sagittal 
COBRE 156 1 Siemens Tim Trio (3) MPRAGE 1 x 1 x 1 Sagittal 
B-SNIP 395 5 
GE Signa (3) 
 Philips Achieva (3) 
 Siemens Allegra (3) 
 Siemens Trio (3) 
 GE Signa HDxt (3) 
 Siemens Trio (3) 
MPRAGE 
IR-SPGR 
1 x 1 x 1 Sagittal 
MCIC 233 4 
Siemens (1.5) 
GE Signa (1.5) 
Siemens Trio (3) 
Siemens (1.5) 




0.625 x 0.625 x1.5 
0.664 x 0.664 x1.6 
0.625 x 0.625 x1.5 
0.625 x 0.625 x1.5 
Coronal 
HUBIN 195 1 GE Signa (1.5) SPGR 1 x 1 x 1 Coronal 
 
In aim 1, data of the SZ group were pooled from three major studies: TOP, FBIRN 3, and 
COBRE. In total, data were obtained from 342 patients with a diagnosis of schizophrenia, 
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schizoaffective, or schizotypal disorders as confirmed by the Structured Clinical Interview for 
Diagnosis (SCID) for DSM-IV or DSM-IV-TR conducted at each study site (Mennigen et al., 
2019). Demographic and scanning information is presented in Table 2. 
Table 2 Demographic and scanning information of SZ participants 
 

















AP medication (in%) 95.6 88.2 91.5 
CPZ equivalent (in 
mg/d) 
542.3 ±1271.4 n/a 516.3 ±1095.4 
PANSS total score 59.2 ±14.6 61.8 ±17 59.9 ±14.3 
Field strength (T) 3 1.5 3 
Sequence MPRAGE MPRAGE MPRAGE 
Voxel size (mm) 1.1 x 0.9 x 1.2 1.3 x 0.9 x 1 1 x 1 x 1 
AP – antipsychotic medication, CPZ – chlorpromazine equivalent. The Superscript a and b indicated the 
result of ANOVA with post-hoc pairwise comparisons (with Bonferroni correction).  
 
The BD study used data from 110 patients with bipolar I (n=69) or II (n=41) diagnoses 
from the TOP study (Jiang et al., 2020; Rimol et al., 2012). Patients met the following criteria to 
be included in the study: 1) aged from 18 to 65 years; 2) understood and spoke a Scandinavian 
language; 3) had no history of severe head trauma; 4) had IQ over 70. The diagnosis of bipolar I 
(DSM-IV 296.0-7) and bipolar 2 (DSM-IV 296.89) was established by the Structured Clinical 
Interview for DSM-IV Axis I Disorders. At the stage of enrollment, the mood status of the 
patients was identified as depressive (n=60), manic (n=5), euthymic (n=40), mixed (n=2), and 
unspecified (n=3). In addition, 54 patients (approximately 50%) experienced at least one lifetime 
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psychotic episode. PANSS scores and structural MRI data were available for all the participants, 
and detailed demographic and scanning information is presented in Table 3.  
 
Table 3 Demographic and scanning information of BD participants 
 
  Mean SD 
Age (years)  34.87 11.65 
Females (N/%)  72 (65%)  
Duration of illness (years)  12.13 10.09 
PANSS positive score  9.81 3.28 
PANSS negative score  9.75 3.54 
PANSS general score  25.42 5.82 
PANSS total score  44.96 10.33 
Field strength (T)  1.5  
Sequence  MPRAGE  
Voxel size (mm)  1.33 x 0.94 x 1  
Scanning orientation  Sagittal  
SD = standard deviation 
2.2.2 Positive and negative symptom scale 
The PANSS is one of the most commonly used questionnaires to assess symptomatology 
in patients with SZ (Kay, Fiszbein, & Opler, 1987). It allows for the assessment of dimension-
specific abnormalities across positive, negative, and general symptoms. In PANSS, the positive 
symptoms score includes delusions, conceptual disorganization, hallucinations, excitement, 
grandiosity, suspiciousness, and hostility. The negative scores includes blunted affect, emotional 
withdrawal, poor rapport, passive/apathetic social withdrawal, difficulty in abstract thinking, lack 
of spontaneity and flow of conversation, and stereotyped thinking. Importantly, PANSS has 
already proved its usefulness in discovering the potential relationship between clinical 
dimensions and brain alterations (Koutsouleris et al., 2008). 
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2.2.3 Preprocessing of imaging data 
T1-weighted structural MRI data were normalized to the standard Montreal Neurological 
Institute (MNI) template using a 12-parameter affine model, resliced to a voxel size of 2 x 2 x 
2mm, and segmented into GM, white matter, and cerebrospinal fluid using Statistical Parametric 
Mapping 12 (SPM12, http://www.fil.ion.ucl.ac.uk/spm/software/spm12/), ending with 
normalized segmented images, prior to smoothing. To identify possible outliers, individual scans 
were correlated with the group-generated GM template, and outliers were visually checked. 
Scans showing low correlations with the group-generated GM template (ρ < 0.98) were 
discarded. In addition, since the pICA would be carried out independently on SZ and BD, the 
regression of age, gender, head motions (subjects with available functional images) and/or site 
was performed on each diagnostic group separately. Voxel-wise regression was applied to 
remove the effects of these three variables on patients with SZ. However, only age and sex were 
included in the regression model for patients with BD. Finally, structural MRI data were 
smoothed with a 10mm Gaussian kernel (Silver, Montana, Nichols, & Alzheimer's Disease 
Neuroimaging, 2011). 
2.2.4 Parallel Independent Component Analysis 
In aim 1, the fusion ICA Toolbox (FIT, http://mialab.mrn.org/software/fit/) was used to 
perform pICA on the smoothed, normalized structural MRI data and raw PANSS scores (30 
items per participant) on SZ and BD separately. The minimum description length (MDL) 
algorithm (Rissanen, 1978) was used to estimate the optimal component numbers of the 
structural MRI data. Each PANSS item was designed to represent distinct psychopathological 
symptoms. Considering the inner structure of the PANSS (positive, negative, and general 
dimensions), the model order was set to three independent components. Importantly, a PANSS 
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component derived from the ICA reflected any combination of PANSS items based on the data 
itself, and the three PANSS components did not necessarily reflect the preset inner structure. 
Within the pICA framework, a GM mask was applied to structural MRI data before ICA was 
performed. To ensure stability of component estimation, infomax ICA ran 20 times, and the 
central point of 20 runs was selected as the final component using ICASSO (Himberg, 
Hyvarinen, & Esposito, 2004). 
The numbers of pairs of GM components and PANSS components varying from 1 to 3 
(default setting) were included and tested according to the actual constrain situation. 




 ) correlation was constrained in the analysis 
in order to yield more stable results. More specifically, the correlation between loading 
coefficients of this structural MRI-PANSS pair was enhanced through pICA, while independence 
within each modality was further maximized. 
2.2.5 Statistical analyses 
Statistical analysis was performed in MATLAB 2017b.( MATLAB and Statistics 
Toolbox Release 2017b, the MathWorks, Inc., Natick, MA ) and SPSS 17.0 (SPSS, Inc., Chicago, 
IL). 
2.2.5.1 Correlation between loading coefficients of sMRI components and PANSS 
components 
To determine whether the loading coefficients of sMRI components correlated with the 
loading coefficients of the PANSS components, the correlation analysis was performed within 
the extracted pairs of sMRI components and PANSS components during the pICA process by 
fusion toolbox. Note that age, gender, and site effects were previously removed from the 
structural brains. The conservative Bonferroni correction was employed for multiple testing. This 
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threshold was decided by all the combinations of all extracted components from both modalities. 
To indicate significance, P values had to exceed .05/(number of sMRI components*number of 
PANSS components). 
In addition, all pICA analyses were validated by 10-fold validation (Salman et al., 2019; 
van der Gaag, Hoffman, et al., 2006). Each validation included 90% of the individuals of the 
sample and was balanced across different study sites if applicable. Parameter settings were the 
same as in the original analysis. The results from each iteration were examined for overlap, i.e., 
correlation, with the original pICA output. 
2.2.5.2 Potential confounders in SZ 
Since the data of SZ patients were selected from multi-center studies, the potential effects 
of study site and illness duration on PANSS scores were explored in a multivariate analysis of 
co-variance (MANCOVA) framework: the 30 PANSS items (multivariate dependent variable) 
were tested for associations with the study site (independent variable) while controlling for 
illness duration (covariate). In addition, the PANSS total scores (dependent variable) were tested 
for an association with study site (independent variable) controlling for illness duration 
(covariate) employing analysis of co-variance (ANCOVA). 
Duration of illness (DOI) and medication status were typical confounders in studies 
involving patients with SZ. In a regression framework, the possible effects of DOI (independent 
variable) on the loading coefficients of the sMRI component and the PANSS component 
(dependent variable) were tested. We tested for the effect of medication on both modality 
loading coefficients in participants for whom chlorpromazine (CPZ) equivalents were available. 
Spearman’s rho was tested because of a skewed distribution. 
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To further explore the relationship between the traditional PANSS dimension scores and 
the data-driven dimensions of the PANSS and sMRI components derived from the pICA, 
correlation analyses were performed on PANSS positive, negative, and general scores and the 
loading coefficients of the components. An alpha level of .05 was applied as our significance 
threshold for all the above analyses. 
2.2.5.3 Potential confounders in BD 
BD patients were collected from one site. However, DOI and medication status were also 
assessed as in the SZ. DOI (predictor) on the loading coefficients of the sMRI component and 
the PANSS component (dependent variable) was tested in a regression framework. We also 
tested the medication effect on the loading coefficients of both modalities with Spearman’s rho. 
Different from CPZ in SZ samples, the current medication status was included as a binary 
variable according to whether or not the patients were currently on antipsychotic, antiepileptic, 
or lithium treatment.  
In addition, the relations of original PANSS subscale scores (positive, negative, and 
general symptoms), PANSS loading coefficients and sMRI loading coefficients from pICA were 
assessed following the same step in SZ patients for correlations. An alpha level of .05 was 
applied as our significance threshold for all the above analyses. 
2.3 Results 
2.3.1 SZ group results 
2.3.1.1 The PANSS scores 
The PANSS total score did not differ significantly between sites of the three different 
studies after controlling for illness duration (F = 1.57, df = 7, p = 0.14). However, the 
MANCOVA revealed significant differences in several PANSS items (see Table 4).  
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Table 4 Significant MANCOVA results of study site differences on PANSS items corrected for 
illness duration at p < 0.05, uncorrected 
 
PANSS item    F statistic               p-value 
P2 Conceptual disorganization 2.18 0.028 
P7 Hostility 2.83 0.005 
N2 Emotional withdrawal 2.01 0.045 
N3 Poor rapport 4.3 <0.001 
N5 Difficulty abstract thinking 12.39 <0.001 
N6 Lack of spontaneity 2.15 0.031 
N7 Stereotyped thinking 2.29 0.021 
G4 Tension 2.13 0.033 
G5 Mannerism 2.86 0.004 
G6 Depression 2.78 0.005 
G9 Unusual thought content 2.18 0.029 
G10 Disorientation 3.83 <0.001 
G11 Poor attention 2.46 0.013 
G12 Lack of judgement 4.12 <0.001 
G13 Disturbance of volition 3.51 <0.001 
G16 Active social avoidance 3.1 0.002 
 
Importantly, items that contributed most to the PANSS component, including delusional 
symptoms (P1), suspiciousness/persecution (P6), and anxiety (G2), were not significantly 

















2.3.1.2 Parallel Independent Component Analysis 
The correlation between the structural MRI and PANSS components was Pearson’s r = 
0.25 (p = 2.62e
-06
, Bonferroni-corrected threshold = 6.67
-04
) shown in Figure 2. The 10-fold 
validation showed that results in 8 out of the 10 validation runs were consistent with findings of 
the original analysis. Given that the correlation was positive, individuals with greater structural 
loading coefficients for this component also showed greater symptom profile loadings. 
PANSS item Z-score 
P1 Delusion 2.87 
P6 Suspiciousness 2.52 
G2 Anxiety 1.24 
P3 Hallucination 1.14 
N3 Poor rapport -1.06 
G13 Disturbance of volition -1.09 
G8 Uncooperativeness -1.22 
G10 Disorientation -1.23 
G5 Mannerisms and posturing -1.31 
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Figure 2 Correlation between loading coefficients of the top PANSS component and the top 
structural MRI component. Pearson’s r = 0.25, p = 2.62e-06 (Bonferroni-corrected threshold = 
6.67e-04) (Mennigen et al., 2019). 
 
The structural MRI component consisted of lower GM concentration in bilateral inferior 
temporal gyrus merging with fusiform gyrus and the gyrus rectus, and higher GM concentration 
in bilateral pre- and postcentral gyrus (see Figure 3a and Table 6).  
The PANSS component was most strongly positively weighted on delusional symptoms 
(P1), hallucinatory behavior (P3), suspiciousness/persecution (P6), and anxiety (G2). Poor 
rapport (N3), mannerism and posturing (G5), uncooperativeness (G8), disorientation (G10), and 
disturbance of volition (G13) were negatively associated with this component (Figure 3b).  
In summary, patients with higher reductions in inferior temporal gyrus and fusiform 
gyrus and increased GM concentration in pre- and postcentral gyrus, also exhibit a more severe 
symptom profile consisting of higher delusional symptoms, suspiciousness, and anxiety and 
lower symptoms of mannerism, disorientation, and uncooperativeness. 
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The 10-fold validation showed high correlation with the original pICA run with a mean 
correlation of Pearson’s r = 0.81; in 2 out of 10 validation runs the directionality of the structural 
MRI component and therefore its association with the PANSS component was inverted. 
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Figure 3 Parallel ICA results in SZ group - the top a) structural MRI and b) PANSS components. 
PANSS items with |Z| >1: P1 – delusion symptoms; P3 – hallucinatory behavior; P6 – 
suspiciousness/ persecution; N3 – poor rapport; G2 – anxiety; G5 – mannerisms and posturing; 
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2.3.1.3 Additional analyses 
The regression models including loading coefficients of the structural MRI component or 
PANSS component (dependent variable) and illness duration (predictor) showed no significant 
association (βsMRI = 0.25, tsMRI = 0.45, psMRI = 0.65; βPANSS = 0.03, tPANSS = 0.62, pPANSS = 0.54). 
Within the subsample with available CPZ equivalents there were no significant 
correlations between CPZ equivalents and the structural MRI loading coefficients (Spearman’s  
= 0.08, p = 0.25) or loading coefficients for the PANSS component (Spearman’s  = 0.12, p = 
0.1). CPZ equivalents did not differ significantly between the two studies providing these data (t 
= -0.15, df = 197, p = 0.89). 
The correlation between the traditional PANSS dimension scores and the experimentally 
derived PANSS loading coefficients revealed high correlations with PANSS positive (Pearson’s 
r = 0.83, p < 0.001), negative (Pearson’s r = 0.51, p < 0.001), and general (Pearson’s r = 0.85, p 
< 0.001) scores. 
Likewise, loading coefficients of the structural MRI component were significantly 
correlated with PANSS positive (Pearson’s r = 0.23, p < 0.001), negative (Pearson’s r = 0.14, p = 
0.008), and general (Pearson’s r = 0.22, p < 0.001) scores. 
2.3.2 BD group results 
2.3.2.1 Parallel Independent Component Analysis 
Two pairs of sMRI and PANSS components showed significant correlations, passing the 
Bonferroni correction threshold of 6.67 x 10
-04 
(determined by 25 sMRI components and 3 
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PANSS components). In the first pair of components, the correlation between the structural MRI 
and PANSS components was Pearson’s r = -0.41 (p = 7.67 x 10
-06
, see Figure 4). In the second 
pair, the correlation was Pearson’s r = -0.35 (p = 1.80 x 10
-04
, see Figure 5). The negative 
correlation indicated that greater loading coefficients of sMRI correlated with lower loadings of 
symptom profile represented by PANSS. 
In the first pair, the sMRI component showed positively contributing GM concentration 
mainly in right middle/superior temporal gyrus in the more medial aspect (extended to inferior 
frontal gyrus, see Figure 4 and Table 7). The corresponding PANSS component was positively 
weighted strongly on anxiety (G2), guilty feelings (G3) and depression (G6); the lack of 
spontaneity and flow of conversation (N6) was negatively associated with this component (see 
Figure 4). Participants with higher preserved GM concentration in right superior/middle temporal 




Figure 4 Parallel ICA results in BD group – ‘mood’ component a) structural MRI and b) PANSS 
component. PANSS items with |Z| >1: N6 – Lack of spontaneity and flow of conversation; G2 – 
Anxiety; G3 – Guilty feelings; G6 – Depression (Jiang et al., 2020). 
 
In the second pair, positively contributing GM concentration was mainly located in 
bilateral middle frontal gyrus, bilateral parietal lobule including postcentral gyrus with temporal 
regions on the left side (left inferior, middle and superior temporal gyrus), and negatively 
contributing GM concentration was located in left supramarginal gyrus for the sMRI component 
(see Figure 5 and Table 7). The PANSS component was positively weighted strongly on blunted 
affect (N1), emotional withdrawal (N2), passive/apathetic social withdrawal (N4), depression 
(G6) and active social avoidance (G16),  and excitement (P4) and guilty feeling (G3) was 
negatively associated with this component (Figure 5). In summary, participants with higher 




Figure 5 Parallel ICA results in BD group – ‘apathy’ component a) structural MRI and b) 
PANSS components. PANSS items with |Z| >1: P4 – Excitement; N1 – Blunted affect; N2 – 
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Emotional withdrawal; N4 – Passive/apathetic social withdrawal; G3 – Guilty feelings; G6 – 
Depression;G16 – Active social avoidance (Jiang et al., 2020). 
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For both components, Z score was set > 3, and cluster volumes were set > 2 cc
3
 to retain their 
most significant results. Brodmann areas are listed for the peak coordinates. The directions of 
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peak Z scores indicate whether the brain region contributed positively or negatively to the 
component as red for positive and blue for negative in brain maps. 
 
2.3.2.2 Additional analyses 
The 10-fold validation showed high correlation with the original pICA results in both of 
the pairs of components. For the first pair, 7 out of 10 validation runs showed similar results to 
the original output, with one of run showing an inverted direction of sMRI and PANSS 
correlation to the other runs. The first pair presented a mean correlation of Pearson’s r = 0.75 of 
above replicated runs. The second pair also presented similar stability, with 7 out of 10 
validation runs showing similar results to the original output and two of the runs showing 
inverted direction of sMRI and PANSS correlation to the other runs. The second pair presented a 
mean correlation of Pearson’s r = 0.67 of its replicated runs. 
In the regression model including loadings coefficients of sMRI components as 
dependent variable and DOI values as predictors, there was no significant association between 
the DOI and component 1 (β = -0.10, t = -1.06, p = 0.29) or component 2 (β = -0.004, t = -0.043, 
p = 0.97). The regression model including loadings coefficients of PANSS components as 
dependent variable and DOIs as predictors also showed no significant association in component 
1 (β = 0.01, t = 0.08, p = 0.94) or component 2 (β = -0.05, t = -0.49, p = 0.63). 
There was no significant correlation between medication status and the sMRI loading 
coefficients in component 1 (Spearman’s ρ = 0.10, p = 0.33) or component 2 (Spearman’s ρ = -
0.06, p = 0.56). In addition, there was no significant correlation between medication status and 
the PANSS loading coefficients in component 1 (Spearman’s ρ = -0.06, p = 0.57) or component 
2 (Spearman’s ρ = -0.14, p = 0.88). 
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In the first pair, the correlation between the original PANSS subscale scores and the 
pICA derived PANSS loading coefficients revealed no association with PANSS positive 
(Pearson’s r = 0.017, p = 0.86), negative (Pearson’s r = 0.15, p = 0.88), or general (Pearson’s r = 
0.062, p = 0.53) scores. In addition, sMRI component loading coefficients were not significantly 
correlated with PANSS positive (Pearson’s r = 0.023, p = 0.82), negative (Pearson’s r = -0.039, p 
= 0.69), and general (Pearson’s r = -0.031, p = 0.75) scores. 
In the second pair, there was also no significant correlation found between the pICA 
PANSS component loading and PANSS positive (Pearson’s r = 0.074, p = 0.45), negative 
(Pearson’s r = 0.11, p = 0.27), or general (Pearson’s r = 0.11, p = 0.26) scores. In the sMRI, the 
loading coefficients were not significantly correlated with PANSS positive (Pearson’s r = 0.072, 
p = 0.45), negative (Pearson’s r = -0.031, p = 0.75) and general (Pearson’s r = -0.061, p = 0.53) 
scores. 




3 AIM 2: PROJECTION OF EXTRACTED BRAIN PATTERNS INTO EITHER 
DIAGNOSTIC GROUP 
3.1 Aim and hypothesis 
In this study, the second aim was to determine if SZ brain components accounted for 
corresponding symptom profiles when projected to the BD samples and vice versa. The 
correlations between the projected loading coefficients of brain and PANSS components were 
tested, and additional correlation analyses between projected loadings of brain patterns and item 
scores of PANSS were tested. We hypothesized that the brain component from SZ or BD will be 




The participants included in aim 2 stayed the same with final subjects included in aim 1. 
Totally 337 SZ and 109 BD participants were included in this analysis 
3.2.2 Data Projection 
The brain and PANSS components of each diagnostic group were projected to each 
other’s preprocessed imaging data and PANSS data to extract the projected loading coefficients. 
Here we used brain components projection to explain the whole process:1) We used the pinv 
function in Matlab to extract all the coordinates of the brain components (positive symptom 
profile related brain component, for example) in the original SZ data (only including voxels 
whose GMC value is larger than 0); 2) We extracted the brain component according to above 
coordinates in the whole output matrix of the pICA in SZ data, and we named it as matrix 1; 3) 
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We used the intersect function in Matlab and generated the shared mask from the mask files of 
SZ and BD data; 4) We read in the preprocessed BD subjects’ images and reshaped it as matrix 2; 
5) Through matrix 1 multiplied by matrix 2 within the shared mask generated in 3), we got the 
projected SZ brain pattern in BD brain images; 6) The projected loading coefficients were 
extracted for further analysis. The projection of BD brain components and PANSS components 
was made through a similar process as above.  
The projection analysis ensured the same brain and PANSS components would be kept 
the same as in the original group, so it was possible to re-assess their correlations in the other 
group. It had to be pointed out here, by making a projection, we assumed the projected pattern 
existed in both of the datasets (Chen et al., 2019; Luo et al., 2018).  
3.2.3 Statistical Analyses 
Statistical analysis was performed in MATLAB 2017b.( MATLAB and Statistics 
Toolbox Release 2017b, the MathWorks, Inc., Natick, MA ) and SPSS 17.0 (SPSS, Inc., Chicago, 
IL). 
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3.2.3.1 Correlation between projected loading coefficients of sMRI components and PANSS 
components 
We tested whether the projected sMRI loading coefficient correlated with the projected 
PANSS loading coefficient and was performed within the sMRI components and the 
corresponding PANSS component in both SZ and BD patients. The conservative Bonferroni 
correction was employed for multiple testing, and a corrected p < .05  was applied as our 
significance threshold for all the analyses. 
3.2.3.2 Correlation between projected loading coefficients of sMRI components and PANSS 
item scores 
Aware of the possibility of the non-existence of PANSS components across the diagnostic 
group, we also explored the potential relationship between projected sMRI components and 
PANSS items. Correlation analyses were performed between sMRI loadings and 30 PANSS item 
scores, positive, negative, and total scores. An alpha level of .05 will be applied as our 
significance threshold for all the above analyses. 
3.3 Results  
3.3.1 PANSS item scores and variations in SZ and BD 
We graphed PANSS items scores and variation levels in SZ and BD for a general map to 
show how these SZ and BD populations might differ from each other clinically. SZ participants 
generally showed a higher level of item scores in most PANSS items. However, BD participants 







Figure 6 PANSS Item scores in SZ vs. BD. In the figure a), blue showed the scores of SZ, and 
yellow showed scores of BD. PANSS items highlighted in previous analysis were marked with 




We also graphed PANSS items score variation levels in SZ and BD. SZ participants 
generally showed higher variation levels in most PANSS items. However, BD participants 




Figure 7 PANSS Item variations in SZ vs. BD. In the figure a), blue showed the variations of SZ, 
and red showed scores of BD. PANSS items showing similar variation levels were marked with 
text. In the figure b) (the radar map), blue showed the scores of SZ, and red showed the scores of 
BD. 
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3.3.2 Projection results from SZ to BD 
After the projection of both positive symptom profiles and related brain patterns from SZ to 
BD, the correlation between brain component and PANSS component showed insignificant 
correlation (Pearson’s r = 0.02, p = 0.84). However, it was weakly in the same direction as the 
original findings (Figure 8). 
 
Figure 8 Projecting brain and PANSS components from SZ to BD. The upper part of the figure 
showed original results in SZ (the positive symptom profile and corresponding brain component). 
The lower part of the figure showed after projecting both of brain and PANSS, they showed 
insignificant correlation while stayed same direction ( Pearson’s r = 0.02, p = 0.84).  
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In addition, the projected brain components showed significant correlation with several 
PANSS items in BD participants, as shown in Table 8. 
Table 8 Projected brain component loadings’ correlation with BD PANSS item scores 
 
PANSS order PANSS items Pearsons’ r P-value 
Positive_05 Grandiosity 0.21 0.026* 









Total positive symptom 
score 
- 0.18 0.068 





Total general symptom 
score 
- 0.18 0.065 
Total PANSS score - 0.16 0.087 
The significant correlations (P value < .05) were marked with asterisk. 
3.3.3 Projection results from BD to SZ 
3.3.3.1 Projection from BD mood symptom profiles and related brain component 
After the projection of both mood symptom profiles and related brain patterns from BD to 
SZ, the correlation between brain component and PANSS component showed an  insignificant 
correlation (Pearson’s r = -0.06, p = 0.27) while it stayed the same direction as the original 
findings (Figure 9). 
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Figure 9 Projecting brain and PANSS components (mood) from BD to SZ. The upper part of the 
figure showed original results in BD (the mood symptom profile and corresponding brain 
component). The lower part of the figure showed after projecting both of brain and PANSS, they 
showed insignificant correlation while stayed same direction ( Pearson’s r = -0.06, p = 0.27). 
 
However, the projected brain components showed significant correlations with several 
PANSS items in SZ participants. For detailed results, see table 9. 
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Table 9 Projected brain component (mood) loadings’ correlation with SZ PANSS item scores 
 





Positive_04 Excitement -0.11 0.047* 





General_08 Uncooperativeness -0.12 0.024* 
General_10 Disorientation -0.17 0.0020* 
General_15 Preoccupation -0.17 0.0020* 
Total positive symptom 
score 
- -0.13 0.020* 





Total general symptom 
score 
- -0.12 0.030* 
Total PANSS score - -0.14 0.012* 
The significant correlations (P value < .05) were marked with asterisk. 
3.3.3.2 Projection form BD apathy symptom profiles and related brain component 
After the projection of both apathy symptom profiles and related brain patterns from BD 
to SZ, the correlation between brain component and PANSS component showed insignificant 
correlation (Pearson’s r = -0.018, p = 0.75) while it stayed the same direction as the original 
findings (Figure 10).  
However, the projected brain components showed significant correlation with PANSS 





Figure 10 Projecting brain and PANSS components (apathy) from BD to SZ. The upper part of 
the figure showed original results in BD (the apathy symptom profile and corresponding brain 
component). The lower part of the figure showed after projecting both of brain and PANSS, they 







4 AIM 3: GENETIC MECHANISM BEHIND IDENTIFIED BRAIN PATTERNS 
4.1 Aim and hypotheses  
The final aim was to determine if the polygenic risks from SZ and BD GWAS results 
(using diagnostic groups as phenotypes) accounted for the identified brain components extracted 
by psychotic symptom profiles in previous aims.  We calculated both the SZ and BD risk scores 
for all individuals. We hypothesized that both polygenic risks from SZ and BD will correlate 
with the brain structural components identified in either diagnostic group. The polygenic risk 
based on disorder risk of SZ will account for the brain structural components extracted by 
symptom profiles in the BD group and vice versa.   
4.2 Methods  
4.2.1 Participants 
This aim included two sets of data. To calculate the polygenic risk for SZ, a combined 
dataset of 526 SZ participants and 611 controls were used. For the calculation of polygenic risk 
for BD, we were not able to acquire genetic data from TOP, so the 156 BD participants from B-
SNIP and the same 611 control participants were used. Table 10 and Table 11 provide detailed 
demographic and site information.  
Table 10 Demographic information for polygenic risk in combined SZ sample 
 
Study Name SZ Number Number of control Age Gender (F:M) 
FBIRN 3 107 120 38.4±11.2 50:177 
TOP 90 163 33.7±9.1 110:143 
COBRE 23 21 38.0±13.1 11:34 
B-SNIP 132 103 35.5±12.4 89:146 
MCIC 99 121 33.7±11.1 73:147 
HUBIN 4 17 37.4±11.0 7:14 
NW 71 66 33.0±13.3 50:87 
Ages were displayed as mean ± standard deviation  
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Table 11 Demographic information for polygenic risk in B-SNIP BD sample 
 
Site GP GT JS CT MB MK 
BD 
Number 
30 28 50 21 7 20 
Age 34.8±12.8 35.8±12.1 34.2±14.4 40.3±10.5 43.1±15.3 35.1±12.1 
Gender 
(F:M) 
16:14 19:9 36:14 16:5 7 13:7 
This sample shared the control groups in the polygenic risk calculation. Ages were displayed as 
mean ± standard deviation  
4.2.2 Preprocessing of Genetic Data 
Site-wise genetic data were merged based on the common SNPs among different studies 
(N = 24.2 millions in SZ data and N = 10.9 millions in BD data). Subjects with >10% SNP 
values missing and SNPs with > 5% values missing were removed from the sample. The minor 
allele frequency was set to 1%, while 10e-6 was set as the threshold for Hardy-Weinberg 
equilibrium. Relatives or family members were checked, and subjects and subjects with 
PI_HAT > 0.18 were removed accordingly. All genetic data used was the hg19 build. Finally, 3.7 
millions SNPs were included in SZ group, and 3.5 millions SNPs were included in the BD group. 
4.2.3 Polygenic Risk Score Calculation 
We employed the GWAS results from Psychiatric Genomics Consortium (PGC) to 
calculate the polygenic risk score (PRS) in both SZ and BD. PRSice-2 (https://www.prsice.info/) 
(https://www.prsice.info/) (Choi & O'Reilly, 2019) were used. In the SZ polygenic risk 
calculation, the PGC schizophrenia study (Schizophrenia Working Group of the Psychiatric 
Genomics, 2014) (https://www.med.unc.edu/pgc/results-and-downloads/scz/) was used as the 
base file while case/control situation in the target data was used as a phenotype to decide the 
threshold applied in PRS modeling. Similarly, the base data for the BD analyses was from the 
PGC bipolar GWAS study, with more than 13 million SNPs (Stahl et al., 2019) 
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(https://www.med.unc.edu/pgc/results-and-downloads/bip/). The full set of GWAS results with 
more than 9 million SNPs was used for PRS analysis (Schizophrenia Working Group of the 
Psychiatric Genomics, 2014).  
 The diagnostic phenotypes were specified as a binary trait. We ran the typical PRS 
calculations, where the association between the PRS and diagnostic phenotypes in the target data 
was tested through logistic regression. The best fitting model of diagnostic phenotypes was 
defined as the set of SNPs for which the PRS explained the greatest variance. The algorithm then 
produced the best fitting p-value threshold, and it gave only one risk score per subject according 
to this threshold (Choi & O'Reilly, 2019). We then checked the correlation between the risk 
score and the loading coefficients of the brain components identified in both SZ and BD in aim 1. 
A similar process was done in the BD risk calculation.  
4.2.4 Statistical Analyses 
Statistical analysis was performed in MATLAB 2017b. (MATLAB and Statistics 
Toolbox Release 2017b, the MathWorks, Inc., Natick, MA) and SPSS 17.0 (SPSS, Inc., Chicago, 
IL). We analyzed whether the polygenic risk score was significantly correlated to the loading 
coefficients of the sMRI components extracted above. Both polygenic risk scores calculated 
from SZ and BD risk were used on all sMRI component loadings. To detail, in the SZ group, SZ 
polygenic risk scores calculated based on SZ case/control difference were tested for correlation 
with the loading coefficients of all sMRI components highlighted in aim 1. We also tested the 
correlation between BD polygenic risk scores calculated based on SZ case/control difference and 
the same brain loadings. The same correlation analyses were run in the BD group. Analyses in 
the BD group only included BD participants from the B-SNIP dataset. Note that the age, gender, 
and site effects were previously removed from the brains, and no DOI or medication effect was 
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detected on previous brain components. Since only one brain feature and two sets of PRS were 
used in SZ group, and two brain features and two sets of PRS were used in BD, a threshold of p 
< .05 was applied as our significance for all the analyses. 
4.3 Results 
4.3.1 Polygenic risk and its correlation with brain component in SZ group 
In the SZ group, the most sensitive p-value threshold to compute PRS based SZ risk was 
0.0013, with 13% of the variance in the case vs. control status explained (p = 1.30E-21, Figure 
11a). Under this threshold, a total of 2.9 millions SNPs were included in the PRS model. 186 SZ 
participants were found with both available polygenic risk scores and brain loadings. The 
polygenic risk scores were highly correlated with positive symptom profile related brain 
component loadings (Pearson’s r = 0.19, p = 8.42E-03, Figure 11b). 
 
Figure 11 The SZ polygenic risk and correlation results in SZ group. A) SZ polygenic risk on 
case vs. control phenotypes in SZ group, by threshold p value on the x axis and variance 
explained by PRS on the y axis. B) The correlation between polygenic risk score and positive 
symptom profile-related brain component loadings (Pearson’s r = 0.19, p = 8.42E-03). 
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The most sensitive p-value threshold to compute PRS based BD risk was 0.0044, with 9.5% 
of the variance in the case vs. control status explained (p = 3.50E-16, Figure 12a). Under this 
threshold, a total of 3.1 millions SNPs were included in the PRS model. The polygenic risk 
scores were highly correlated with positive symptom profile related brain component loadings 
(Pearson’s r = 0.21, p = 5.11E-03, Figure 12b). 
 
Figure 12 The BD polygenic risk and correlation results in SZ group, similar to Figure 11. The 
correlation between polygenic risk score and positive symptom profile-related brain component 
loadings was Pearson’s r = 0.21, p = 5.11E-03. 
 
4.3.2 Polygenic risk and its correlation with brain component in BD group 
The most sensitive p-value threshold to compute PRS based BD risk was 1.00E-04, with 
8.8% of the variance in the case vs. control status explained (p = 5.60E-11, Figure 13a). Under 
this threshold, a total of 2.9 millions SNPs were included in the PRS model. The most 
sensitive p-value threshold to compute PRS based SZ risk was 0.012, with 6.1% of the variance 
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in the case vs. control status explained (p = 8.00E-09, Figure 13b). Under this threshold, a total 
of 2.8 millions SNPs were included in the PRS model. 
4.3.2.1 Correlation analysis between PRS and mood component 
Among the 156 BD participants, we were able to access the usable images for 140 out of 
the total B-SNIP sample. The projected loadings in these brains from previously identified brain 
component of mood and apathy components were used in following analyses. The BD risk 
scores were correlated with mood symptom profile related brain component loadings (Pearson’s 
r = -0.17, p = 0.040, Figure 14a).  
 
Figure 13 The polygenic risk results in BD group. In the figure, a) the BD polygenic risk based 
on case vs. control phenotypes in BD group, by threshold p value on the x axis and variance 
explained by PRS on the y axis. The figure b) showed SZ polygenic risk on case vs. control 
phenotypes in BD group similar to figure a). 
 
The SZ risk scores were also correlated with mood symptom profile related brain 
component loadings (Pearson’s r = -0.33, p = 6.21E-05, Figure 14b). 
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Figure 14 The correlation results of PRS and projected mood component in BD group. In figure 
a), the BD polygenic risk scores were negatively correlated with the projected mood profile-
related brain component loadings (Pearson’s r = -0.17, p = 0.040). In figure b) the SZ polygenic 
risk scores were negatively correlated with the same projected mood profile related brain 
component loadings (Pearson’s r = -0.33, p = 6.21E-05). 
 
4.3.2.2 Correlation analysis between PRS and apathy component 
No direct relationship between the PRS and projected apathy brain component loadings 
was found. However, considering the possibilities of  missing information during the data 
projections, we did an another ICA analysis on the B-SNIP BD participants’ brain independently 
(25 brain components). We extracted the brain components most similar to apathy component, 
both by visual checking, and with a maximal GMC correlation ( Pearson’s r = 0.20, p < 10E-06). 
See figure 15. 
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Figure 15 Comparing original apathy component and similar brain component generated from 
ICA in B-SNIP BD brains. The upper brains were the original apathy brain component, and the 
lower part showed the most similar brain component generated independently in B-SNIP. The 
GMC values of both brain components were correlated at r = 0.20, p < 10E-06. 
 
The SZ risk scores were found correlated with brain component loadings (Pearson’s r = -
0.31, p = 2.30E-04). See figure 16. 
 
Figure 16 The correlation between PRS and apathy-like brain components. PRS was negative 
correlated with this brain component (Pearson’s r = -0.31, p = 2.30E-04). 
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5 DISCUSSION AND CONCLUSIONS  
5.1 Summary 
 This study first investigated the brain patterns guided by symptom profiles within the SZ 
and BD framework, and potentially shared mechanism were observed at genetic, brain, and 
clinical levels. We identified distinct brain patterns correlated with positive symptom, mood, and 
apathy symptom profiles across SZ and BD. In addition, after projecting across diagnostic 
groups, these brain patterns were correlated with grandiosity, as well as several remaining 
positive, and general psychotic symptoms. It indicated these brain pattern were connected to 
more complicated and broad symptom profiles. Most importantly, both polygenic risk scores 
based on SZ and BD risk were highly correlated with the brain patterns (loading coefficients in 
the GMC brain components) identified here. It suggests that the highly shared genomic risks 
exhibit strong effects on brain circuits alterations behind different psychiatric disorders as SZ 
and BD .  
Through data-driven multivariate analysis such as pICA, we extracted these brain 
patterns behind typical symptom profiles of psychotic and mood disorders, respectively. 
Specifically, these highlighted brain regions were spreading across the frontal (sensorimotor 
regions and inferior/middle frontal gyrus), temporal (inferior/middle/superior temporal gyrus and 
fusiform gyrus), and parietal (sensorimotor regions and inferior parietal lobule) lobes, which 
were also the cortical deficits shared by SZ and BD (Hibar et al., 2018; van Erp et al., 2018). 
Lower GMC in these regions consistently correlated with worse clinical symptoms detected by 
PANSS (higher PANSS scores) across SZ and BD groups. 
To further investigate the relationships behind symptoms profiles and identified brain 
patterns across disorders, we did the projection analysis to determine the disorder specificity or 
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generalizability of these findings. We found that the brain components previously identified  in 
each disorder separately showed a more complicated and partially shared clinical significance 
across psychotic and mood symptoms in the other disorder. The  brain pattern identified in SZ 
showed various connections with grandiosity, hostility, poor impulse control, and active social 
avoidance in BD. Correspondingly, the brain patterns discovered by mood and apathy symptom 
profiles in BD, showed associations with grandiosity, excitement, conceptual disorganization, 
disorientation, and preoccupation when projected into SZ participants. A single symptom was 
not anchored to a single brain region, and brain regions could play multiple roles in other 
symptoms (Hare et al., 2018; Walton et al., 2018). Our findings enhanced this understanding 
across diagnostically.  
We tried to explore whether there was a shared genetic mechanism or risks behind the 
brain patterns detected in the final aim. Based on the most extensive genetic studies from the 
PGC cohort, we produced the PRS from the alleles carrying SZ risk that best accounted for 
diagnostic effects in SZ and BD groups. We also calculated the PRS from the alleles carrying 
BD risk in the same way for both groups. Notably, both sets of SZ and BD risk scores were 
correlated with brain patterns identified regardless of the original diagnostic groups. Specifically, 
in the SZ participants, higher genetic risk of SZ and BD accounted for lower GMC (more severe 
GMC reductions) in the sensorimotor and temporal regions as identified by positive symptom 
profiles. As in the BD group, same correlations were detected between both disorders’ PRS and 
mood symptom related brain component within the frontal-temporal-parietal circuits. However, 
the relationship between PRS and apathy component was subtle. Our hypotheses of a shared 
genetic mechanism were partially supported. 
52 
5.2 Symptom profiles reveal distinct brain patterns in SZ and BD 
5.2.1 Positive symptom profile revealed temporal and sensorimotor brain patterns in SZ 
The brain structures underlying psychiatric symptoms are not mapped to a single 
symptom. Networks of regions are related to groups of symptoms (Hare et al., 2017; Modinos et 
al., 2013; Shinn et al., 2012; Walton et al., 2018). The positive symptoms main PANSS 
component correlated with GMC in a network mainly located in the inferior temporal and pre-
and postcentral regions (sensorimotor areas). The PANSS component differed from the 
traditional dimensions of the PANSS. It could be broadly described as symptomatology 
characteristic of a chronic form previously described as paranoid schizophrenia (Tandon et al., 
2013). In addition, this PANSS component's loading coefficients correlated strongly with the 
PANSS general and positive scores, indicating that participants with more severe overall 
symptoms also showed higher loading coefficients for this component. 
As for the structural MRI data, lower GMC often observed in schizophrenia is generally 
understood as reductions in neuron density (Harrison, 1999; Todtenkopf et al., 2005) and 
changes in the glia compartment (Fornito et al., 2009). Reduced GMC concentration and cortical 
thickness often coexist (Narr et al., 2005), though they might reflect different pathophysiological 
processes (Fornito et al., 2009). Also, these reductions could be caused by antipsychotic 
treatment (Huhtaniska et al., 2017; Vita et al., 2015). However, our post-hoc analyses did not 
reveal any significant association between the loading coefficients of structural brain component 
and CPZ equivalents.  
The brain pattern identified here replicated some previous multivariate findings regarding 
cortical thickness and GM volume in schizophrenia. Padmanabhan et al. (2015) applied factor 
analyses to structural brains (GM volume, cortical thickness, and surface area) showing 
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associations with the PANSS positive scale. A temporal factor that included the cortical 
thickness of the bilateral inferior temporal gyrus and bilateral fusiform gyrus, was identified, and 
it was a significant predictor of PANSS positive scores (Padmanabhan et al., 2015). We showed 
similar GMC alterations in inferior temporal gyrus and fusiform gyrus with a different 
multivariate approach with expanded associations with psychotic symptom profiles. The GMC 
alterations in these regions have also been associated with a lack of insight (Bergé et al., 2011; 
Cropley et al., 2016; Ha et al., 2004). Lack of insight was also thought to be correlated with 
positive symptoms, which might explain these overlapping brain structures (Pousa et al., 2017). 
Besides, cortical thickness of inferior temporal and fusiform gyrus exhibited the most robust 
reductions in schizophrenia patients, suggesting that these regions may indeed be strongly 
associated with the psychotic pathophysiology (van Erp et al., 2018).  
Higher GMC in sensorimotor regions also contributed to the identified structural MRI 
component. Previous studies have revealed inconsistent findings regarding alterations of GMC in 
schizophrenia. Whereas smaller samples (Ha et al., 2004; Narr et al., 2005) showed higher GMC, 
studies with larger sample showed lower GMC  (Ivleva et al., 2017). Interestingly, none of these 
studies observed any association with clinical symptoms as we identified, so higher GMC in 
sensorimotor regions was associated with a specific pattern of the PANSS, which might explain 
the divergent findings (Ha et al., 2004; Ivleva et al., 2017; Narr et al., 2005). 
5.2.2 Mood and apathy symptom profiles revealed frontal, temporal, and parietal brain 
patterns 
In the BD analyses, we found two GMC networks that were related to two different 
patterns of symptom severity profiles. Importantly, the PANSS profiles highlighted here were 
not constructed according to the typical preset of PANSS subscales, but the underlying 
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relationships with GMC patterns drove them. The mood symptom profile was correlated with 
GMC reductions in the right temporal regions, while in contrast, the apathy/asocial symptom 
profile was correlated with more widespread network deficits, including frontal, temporal, and 
parietal regions. It implicated the GMC deficits in the temporal lobe and frontal-temporal-
parietal circuits related to clinical profiles as mood and apathy. 
The PANSS component for mood mainly included anxiety, guilty feelings, and 
depression, contrasting with the symptoms of lack of spontaneity and flow of conversation but 
less strongly. This represented a generally negative mood component, but differing from the 
original design of the PANSS dimensions. This mood component showed similar affective items 
highlighted in studies of affective temperaments (Rihmer, Akiskal, Rihmer, & Akiskal, 2010).  
The temporal regions’ deficits are common in BD and other psychiatric disorder (Abe et al., 
2016; Hanford, Nazarov, Hall, & Sassi, 2016; Whalley et al., 2012). However, its relationship 
with mood symptoms has been elusive, and few studies formed a direct association between 
mood symptoms and brain structure alterations (Busatto, 2013; Hozer & Houenou, 2016; 
Padmanabhan et al., 2015; Palaniyappan & Cousins, 2010; Selvaraj et al., 2012). Among 
psychiatric symptoms, temporal regions (mostly in the superior temporal gyrus) were believed to 
be critical in thought disorders, auditory verbal hallucinations, and overall positive symptom 
domains in psychosis (Cavelti et al., 2018; Morch-Johnsen et al., 2018; Morch-Johnsen et al., 
2017; Padmanabhan et al., 2015; Strik et al., 2017). However, mood symptoms were usually 
believed to be marked across several large regions, including frontal, temporal, and limbic 
regions (Garety & Freeman, 2013; Lebow & Chen, 2016; Ramirez et al., 2015). The structural 
brain studies emphasized multiple temporal regions' involvement, especially the superior 
temporal gyrus (Hanford et al., 2016). Cortical thickness in the right superior frontal and superior 
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temporal has previously been negatively correlated with symptom severity measured on the 
Hamilton Depression Rating Scale (Maller, Thaveenthiran, Thomson, McQueen, & Fitzgerald, 
2014). In addition, cortical thickness reduction in the middle temporal gyrus was negatively 
correlated with the global functioning assessment. Despite these significant structure/mood 
symptom studies, imaging research in BD often reported no correlation between these structural 
alterations and mood symptom severity (Doan et al., 2017; Elvsashagen et al., 2013; Hanford et 
al., 2016; Lan et al., 2014; Ratnanather et al., 2014).  
Functional studies provided some evidence to support the engagement of temporal gyrus 
in mood symptoms and regulations (Whalley et al., 2012). An emotional prosody task indicated 
patients with BD exhibited stronger activations in the bilateral superior temporal gyrus and right 
inferior frontal gyrus (Mitchell, Elliott, Barry, Cruttenden, & Woodruff, 2004). In addition, in an 
emotional memory task, the superior temporal gyrus was highlighted with stronger activations 
(Whalley et al., 2009). Our findings revisited the critical roles of the frontal (inferior frontal 
gyrus) and temporal (superior/middle temporal gyrus) regions involved in mood symptoms and 
processes. In summary, compared to most null or inconsistent findings in BD populations 
discussed above, we exhibited the association between GMC deficits in a specific frontal-
temporal brain pattern and mood symptoms through multimodality multivariate analysis. 
Through aggregating several related items describing mood status in PANSS and localized brain 
spots that may work together, enhanced brain and clinical phenotypes connection was clearly 
revealed. It indicated the usefulness of such multimodality multivariate analysis in raising the 
heterogeneity of future studies. Additionally, we would try to discuss mood symptom profile 
related brains and its implication to our understanding of BD and disorder boundaries along with 
apathy in following part.   
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Apathy is commonly observed in psychotic disorders (Grande, Berk, Birmaher, & Vieta, 
2016). The PANSS component for the apathy was strongly weighted on blunted affect, 
emotional withdrawal, passive/apathetic social withdrawal, depression, and active social 
avoidance, while negatively contributed by excitement and guilty feeling. In addition to negative 
symptoms, this component included all the withdrawal/avoidance items in PANSS. It reflected 
itself as a combination of negative symptoms and behavioral deficits involving avoidance and 
asociality. In schizophrenia research, a two-factor model categorized anhedonia-asociality-
avolition into a general motivation and pleasure (MAP) factor and alogia/blunted affect into an 
expressive (EXP) factor. However, asociality was not included (Jang et al., 2016). In addition, 
apathy was another common term used to describe motivational deficits. Moreover, previous 
studies in the TOP project investigated the relationship between the Apathy Evaluation Scale 
(AES) and PANSS apathy scores (Faerden et al., 2009; Faerden et al., 2008; Morch-Johnsen et 
al., 2015). In these studies, apathy scores were formed from emotional withdrawal (N2), 
passive/apathetic social withdrawal (N4), and lack of spontaneity and flow of conversation (N6) 
were chosen to compare its capability with AES, while N2 and N4 were chosen according to the 
definition of apathy by Marin (Marin, Biedrzycki, & Firinciogullari, 1991). It was found that the 
apathy items chosen from PANSS were significantly correlated with AES.  
Through the pICA approach, we found emotional withdrawal, passive/apathetic social 
withdrawal, blunted affect, and depression included in the apathy symptom profile. Social 
avoidance can be more complicated. Active social avoidance often refers to the social avoidance 
caused by unwarranted fear, hostility, or distrust (Hansen, Torgalsboen, Melle, & Bell, 2009). 
Some studies argued it was weighted on positive symptoms (van der Gaag, Cuijpers, et al., 2006), 
while others believed it was related to depression or anxiety (Bell, Lysaker, Beam-Goulet, 
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Milstein, & Lindenmayer, 1994). It was also suggested that social avoidance might not be related 
to the preset factors of PANSS items (White, Harvey, Opler, & Lindenmayer, 1997). We suggest 
active social avoidance, regardless of the cause, should be seen as part of asociality grouped into 
this apathy component. Besides, similar to the mood component, this apathy component was also 
constructed out of the subscales of PANSS. Through the automatic data reduction process, active 
social avoidance survived and contributed strongly to the profile. This apathy component 
described another unique clinical observation of BD patients in the TOP research.  
The frontal-parietal-temporal circuit pattern related to the apathy component reflects 
significant brain deficits previously found in patients with BD (Dusi et al., 2019; Han, De 
Berardis, Fornaro, & Kim, 2019; Shahab et al., 2018). Connectome research suggested the 
frontal-parietal circuit relates to the positive and negative symptoms assessed by PANSS, though 
the structural connectivity could not predict symptom dimensions (Wang et al., 2018). Another 
informative comparison among SZ and BD was suggested by the B-SNIP (Clementz et al., 2016; 
Ivleva et al., 2016; Meda et al., 2015). As noted previously from that analysis, more SZ 
participants were in type 1 while more BD participants were in the other biotypes. The GMC 
reductions of different types were as following: type 1  (higher proportion of SZ) showed GMC 
loss across the whole brain, while type 2 (similar proportion of SZ, SAD, and BD) largely 
overlapped with type 1, and the largest effects were in fronto-temporal circuits, parietal lobes, 
and cerebellum. Type 3 (higher proportion of BD participants) showed localized GMC 
reductions in frontal, cingulate, and temporal regions despite the DSM diagnoses (Ivleva et al., 
2016). Our findings in BD showed similar but more complicated maps detailed by specific 
symptom profiles. The brain patterns driven by apathy symptoms showed relative spread deficits 
across frontal, temporal, and parietal regions as type2 (balanced SZ, SAD, and BD grouped 
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together). Notably, apathy has been often differentiated from simply depressive mood for its 
potential psychotic features (Morch-Johnsen et al., 2015). This connection added to the evidence 
for placing BD between SZ and affective disorder by DSM-5 (American Psychiatric Association, 
2013) while emphasizing its characteristics as psychotic disorder. However, the brain patterns 
driven by mood symptoms showed similar localized brain deficits in frontal and temporal 
regions as type3 (BD main biotype). Thus, it reflected the evidence of BD being categorized as 
an affective disorder. Our results stayed in line with the idea BD is between psychotic and 
affective disorders, and we were able to separate coexisting psychotic and affective brain 
patterns in another BD population. 
It must be pointed out that manic symptoms were the typical positive symptoms expected 
in BD patients (Dell'osso et al., 2009). These positive symptoms did not emerge through PANSS 
in this analysis. However, this may be interepreted that these symptoms do not show the 
strongest relationships with brain structure; or it may be that the range of severity on those 
symptoms was not large in this sample. Among the three PANSS components in BD group, there 
was a component highlighted by excitement (Z-score = 1.4) and grandiosity (Z-score = 2.2). It 
indicated enough variations in positive symptom items for pICA to capture, though its 
correlation with the brain patterns failed to reach significance (P = 0.073). This brain pattern 
included mainly the inferior/middle frontal gyrus and cerebellum. The frontal gyrus reductions in 
GM, especially in inferior frontal and prefrontal regions, were reported connected with mania 
episodic times in follow-up studies (Abe et al., 2016; Abe et al., 2020). However, other studies 
found heterogeneous cortical deficits or no significant results regarding the above regions and 
their relationship with manic symptom (Cotovio et al., 2020). Notably, there was a divergence 
between BD-I and BD-II; in the BD-II participants, the cortical thinning in the prefrontal, frontal, 
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and temporal regions were found to connect to the depressive episodic times, not hypomania 
(Elvsashagen et al., 2013; Zak et al., 2019). In summary, our analysis was not able to pick up the 
manic symptoms, but the heterogeneity of data (especially including BD-I and BD-II at the same 
time) and complexity between manic symptoms and mapping to structural brains might lead to 
the insignificance of the findings. 
Similarly, we did not get medication or DOI effects on PANSS or brain structures in the 
highlighted components. Previous studies found medication exposure positively affecting brain 
structures through various pathways (Dell'Osso, Del Grande, Gesi, Carmassi, & Musetti, 2016; 
Di Sero et al., 2019; Hartberg et al., 2015; Jorgensen et al., 2016), and large scale studies found 
medication effects in cortical and subcortical brain regions (Hibar et al., 2018; Hibar et al., 2016). 
The DOI showed similar findings through the strongest effect found in cortical thickness (Hibar 
et al., 2018). The pICA approach prioritized the correlation between the PANSS scores and 
structural brains during the data reduction process, so these components did not necessarily 
reflect brain regions most significantly affected by medication or DOI.  
5.3 The relationship of projected brain patterns and symptoms across disorders 
Data projection allows the re-assessments of correlations between previously associated 
pairs of patterns to be possible across different datasets. As mentioned, SZ and BD have different 
clinical symptomatology, as reflected by PANSS scores and variations. In addition, being aware 
that during an independent ICA process, the projected PANSS profiles patterns might not reveal 
themselves across diagnostically, we further checked the correlations between projected brain 
loadings and single PANSS item, positive, negative, general, and total scores. Thurs, we avoided 
missing the potential association between projected brain patterns and symptoms profiles.  
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The projections results from SZ to BD included several exciting findings. Rather than 
staying connected with the same positive symptom profile across disorders, the brain pattern 
identified in SZ positive symptom profile showed various connections with grandiosity, hostility, 
poor impulse control, and active social avoidance after being projected into the BD group. 
Correspondingly, after being projected, the brain patterns extracted by mood and apathy 
symptom profiles in the BD, showed associations with grandiosity, excitement, conceptual 
disorganization, disorientation, and preoccupation. They also showed insignificant correlations 
(though the same direction) with projected PANSS mood and apathy profiles, which were 
previously associated. 
These results were not totally out of expectations. Three brain patterns extracted by 
PANSS in SZ and BD fell in the shared brain regions reported previously. As mentioned before, 
with a large cohort meta-analysis of sMRI studies, the ENIGMA bipolar working group 
identified consistent and robust thinner frontal, temporal, and parietal cortex (Hibar et al., 2018) 
in BD patients compared to controls. These differences show overlap with brain structural 
differences also found in SZ (Rimol et al., 2010; Rimol et al., 2012; van Erp et al., 2018). In a 
broader view of various brain diseases (including SZ, BD, depression, anxiety, obsessive-
compulsive disorder, and addiction), GM losses often converged and became less diagnostic-
specific through a longer life span (Goodkind et al., 2015; Kaufmann et al., 2019). Importantly, 
the identified and projected brain patterns in our work overlapped greatly with these regions 
including frontal-temporal-parietal circuits and key spots as inferior/middle/superior temporal 
gyrus.  
In the clinical observation, there were same trends of shared cognitive declines behind 
these common brain alterations in SZ, BD, and other psychiatric disorders (Chang et al., 2018; 
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Trotta, Murray, & MacCabe, 2015). Psychomotor speed, executive function, and learning 
abilities along with intelligence are relatively impaired simultaneously in SZ and BD, and it is 
also challenging to figure the brain pattern abnormalities that distinguish between SZ and BD 
(Chang et al., 2018; Knochel et al., 2016; Molina et al., 2011). However, the shared 
symptomatology with these brain circuits between SZ and BD can be elusive (Nery, Monkul, & 
Lafer, 2013), and inconsistent findings have been often reported even in BD patients with 
psychotic symptoms (Ivleva et al., 2012; Yuksel et al., 2012). Importantly, a recent multivariate 
analysis revealed some potentially supporting findings. Through group pICA, negative 
symptoms were found to be shared between SZ and depression participants by GMV circuits 
including caudate, thalamus, middle temporal gyrus, and inferior temporal gyrus (Qi et al., 2020). 
In this work, the PANSS negative item and Hamilton Rating Scale for Depression (HRSD) were 
working cross-diagnostically to reveal the shared brain patterns behind the same symptom 
feature. Brain components in the inferior/middle temporal gyrus were highlighted again among 
the different diagnostic groups. In our studies, within the respective disorder group, the psychotic 
symptom profiles (positive symptom and apathy) related brain patterns (broader coverage of 
regions spanning sensorimotor cortex and frontal-temporal-parietal circuit) emphasized the 
psychotic characteristics of SZ and BD. The affective symptom profiles (mood symptoms consist 
of anxiety, depression, and guilty feelings) related brain regions (relatively localized deficits in 
frontal-temporal regions) reflected the affective characteristics of BD. Our projection findings, 
on the other hand, exhibited potentially shared psychotic features behind the frontal-temporal-
parietal circuit and frontal-temporal regions among SZ and BD. The projected brains related 
symptoms, including positive symptoms such as grandiosity, excitement, and hostility, along 
with others, were strongly involved in common psychotic symptoms in SZ and BD. This 
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situation indicated the specific brain patterns accounting for disorder-specific symptoms profiles 
such as delusional positive symptoms, apathy, and mood could distinguish psychotic and 
affective disorders to some extent. Simultaneously, they may also potentially contributed to 
broadly shared psychotic features between SZ and BD while the significance was limited to the 
levels of clinical observations circumstantially.  
The reasons why the brain patterns failed to show correlations with original the PANSS 
patterns after the cross-diagnostic projection should be considered. These include potentially the 
conservative settings applied to the pICA algorithm, and the logic of the pICA process. The 
pICA was designed to prioritize the correlation between the modalities and extract the most 
significant results according to such correlations (Pearlson et al., 2015). To improve the constrain 
stability, we were quite conservative in the estimated component numbers in the imaging and 
symptom data (twenty-five brain components and three PANSS components respectively). Also, 
one pair of components from both modalities in SZ, and three pairs (two passed significance) in 
BD were prioritized through the iterative pICA process. With above setting, only positive 
symptoms, mood, and apathy symptom profiles survived the pICA approach. It didn’t cover all 
the potentially correlated symptom profiles and brain patterns. This choice conservatively 
reduced the cross-diagnostic representation for the original PANSS patterns from brain 
components. However, despite this conservative application, we could still detect broad 
associations between brain patterns and symptom profiles after projection. These findings again 
indicated the shared brain alterations and clinical relevance behind SZ and BD. 
5.4 Genetic effects on symptom profiles driven brain patterns across disorders 
In the search for a polygenic mechanism, we were able to find common diagnostic gene 
risk behind brain patterns extracted by PANSS profiles regardless of the original diagnostic 
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groups. As presented above, both polygenic risks of SZ and BD were accounting for the brain 
alterations behind disorders with the comparable significance of the association. Our findings 
were indicating the highly shared genome-wide risk across psychiatric disorders. 
It was worth pointing out, the polygenic risks and brain structural alterations in 
psychiatric disorders often report inconsistent findings (van der Merwe et al., 2019). The earlier 
studies in SZ, including around 100 genetic variations, reported no significant relationship with 
any cortical thickness or white matter measures as fusion images (Voineskos et al., 2016). A 
similar situation was described in the BD population, while BD was not usually studied alone for 
the association between polygenic risks and brain structures. Among the limited studies, they 
often reported insignificant findings (Ranlund et al., 2018). As the increasing genetic variations 
and sample size were included in the analysis, more encouraging results have been provided. It 
remains unclear whether the polygenic risk accounts for white matter changes or vast subcortical 
volume deficits in psychiatric disorders, including SZ and BD (Grama et al., 2020; Reus et al., 
2017; Simoes et al., 2020). However, cortical deficits and their association with PRS have been 
identified robustly. In a combined analysis including 16 cross-sectional data, heterogeneous 
deficits within cortical thickness, cortical area, cortical volumes, ventricle volumes, and 
hippocampal subregions were found in SZ vs. controls. Among these regions, higher PRS was 
associated with thinner frontal and temporal brain cortices along with smaller hippocampal 
subregions in UK Biobank data (Alnaes et al., 2019). In BD, the situation with cortical 
anatomical features becomes more complicated. It is not yet clear whether the cortical thickness, 
GMC, or anatomical measures in BD are stably explained by PRS (Ranlund et al., 2018). It has 
been reported there was a positive correlation between PRS calculated based on PGC BD results 
and the longitudinal changes of cortical thickness in medial occipital gyrus, central sulcus, and 
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posterior cingulate (Abe et al., 2020). However, these regions were not typically highlighted in 
the frontal-temporal-parietal circuits. A multivariate study showed widespread changes in whole 
brain GMC might help predict the PRS in five psychiatric disorders, including SZ, BD, and 
others, but this would need further replication (Ranlund et al., 2018). Among all the above 
inconsistent findings, it seems polygenic effects on cortical regions are repeatedly reported in SZ 
but not BD. In addition, the localization of these spots showing the strongest PRS effects are 
varying from study to study. On the other hand, our results exhibit both SZ and BD polygenic 
risks consistently affect the cortical abnormalities in frontal, temporal, and sensorimotor regions. 
Notably, cortical deficits in a larger network as the frontal-temporal-parietal circuit, though 
extracted in BD, is only associated with SZ polygenic risk. It indicates that SZ polygenic risks 
show stronger and broader effects across all cortical brain deficits than SZ and BD's shared 
effects. 
Additionally, we did not find a direct relationship between PRS and the PANSS symptom 
profiles. PANSS general scores have been previously correlated with PRS, though it was in first-
episode SZ rather than a longer duration of illness as in our sample (Sengupta et al., 2017). 
Generally, the exact map of the relationship between PRS and clinical/behavioral phenotypes is 
challenging to draw at this moment, especially in cross diagnostic studies (Dima & Breen, 2015; 
Smeland et al., 2019). In current diagnostic categories, BD-I might exhibit higher SZ RPS in 
BD-I with manic psychosis than BD-I with depressive psychosis, BD-II, and controls (Markota 
et al., 2018). In a combined population of SZ, BD, and depression, the polygenic liability for SZ, 
BD, and depression was associated with the risk of depression, and it was to predict early onset 
of depression in BD (Musliner et al., 2019). Similar SZ polygenic liability predicted the chances 
of occurrence and the level of mood-incongruent psychotic symptoms in BD (Allardyce et al., 
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2018). Additionally, SZ and BD showed comparable polygenic effects on the memory (Dezhina, 
Ranlund, Kyriakopoulos, Williams, & Dima, 2019), emotional processing (Wang et al., 2018), 
spatial visualization (Ranlund et al., 2018), anhedonia (Ward et al., 2019), immune and 
metabolic serum markers (Maj et al., 2020). More complicated results were suggested, as we 
mentioned above, regarding the distinguishing of diagnostic features through PRS and clinical 
phenotypes in SZ and BD. PRS methods revealed loci distinguishing between BD and SZ 
through psychotic symptoms and the age of onset of the BD participants (Bipolar Disorder 
Schizophrenia Working Group of the Psychiatric Genomics Consortium, 2018). However, using 
the PGC data, the PRS provided only modest effects in distinguishing SZ, BD, and unaffected 
relatives (Calafato et al., 2018). The difficulty in revealing direct relationships between 
polygenic risks and clinical or behavioral phenotypes might point to the original idea and 
usefulness of applying imaging genetics. In our analysis, we were still able to capture PANSS 
associated brain alterations as the intermediate phenotypes, while the direct association between 
genes and PANSS measures was missing. In addition, despite the PANSS components remaining 
distinct in SZ and BD, the PRS appeared more useful in exploring the shared features in brains, 
phenotypes, and clinical observations rather than the disease-specific ones (Calafato et al., 2018; 
Dima & Breen, 2015; Fullerton & Nurnberger, 2019).In summary, it’s still hard to reveal the 
direct relationships between polygenic risk scores and clinical phenotypes. We will discuss better 
ways to draw the map of polygenic effects on brains and behavioral phenotypes in future 
directions. 
5.5 Limitations 
There are inevitable limitations within this work. The data used in this work were pooled 
from multiple datasets. The availability of other data modalities (genes, brains, and behavior) 
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limited the usable numbers of participants within different aims and might impair comparability 
among different aims. To extract PANSS profiles related to brain patterns, we were able to use 
337 SZ and 109 BD. Though the same number of participants were included in projection 
analysis, we used quite different participants in genetic analysis. More than 1000 participants 
were included in polygenic risk calculation in the SZ group to utilize as many participants as 
possible. However, among the participants with available genetic data, 186 of SZ were finally 
found with both available genetic and brain imaging data. Thus, a relatively small proportion of 
the data were included in the final aim. 
There were also some limitations in the demographic background of the data. The 
different studies included more than 15 sites, with a variety of data collection techniques. The 
BD participants, collected at one site, were diagnosed with bipolar spectrum disorders, including 
bipolar I and II, and around half of the patients experienced at least one psychotic episode 
(Nesvag et al., 2017; Wolfers et al., 2018). The history of manic episodes, along with euthymia 
periods and their potential effects on brain structures and PANSS profiles, could not be taken 
into consideration. In addition, the proportion of lifetime psychotic episode might differ from the 
larger BD population overall. We tried to control for age, gender, and site/scanning difference 
with their potential effects on the brains. Also, we evaluated DOI and medication with their 
effects on brains and PANSS items. However, with missing data on medications in the SZ group, 
we could only assess medication effects on participants with available CPZ estimates. In the BD 
group, considering lithium, antipsychotic, and antiepileptic treatment and their potential effects 
on brain structures, the medication status was checked as binary variable on the brain structures 
and PANSS scores. However, the exact dosage and dosage-related effects could not be examined 
on brains and PANSS scores. 
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There were chances of overfitting and randomization during the pICA approach. We 
made an effort to enhance the stability of the results. 10-fold validations were applied to pICA to 
avoid results being driven by outliners, and pICA itself was running with ICASSO to ensure 
stability. By introducing a 10mm smoothing kernel (Gupta et al., 2015; Segall et al., 2009; Silver 
et al., 2011), using a relatively strict Z score, and cluster size to filter the structural brain, the 
main findings were restricted to the cortical regions. It must be pointed out, in our earlier work 
applying SBM analysis to GMC (Gupta et al., 2015), we found similar structural brain case vs. 
control differences as in the current work. However, we did not identify an association between 
GM concentration and the PANSS positive score when applying post hoc correlation analyses. 
During the projection analysis process, as highlighted in the discussion part, one 
inevitable limitation was that the projection did not ensure the existence of the component in the 
target data. The other limitation might be that the projection was limited to the shared brain mask 
and voxels across different datasets (Chen et al., 2019). Though we were able to do it with the 
full frame of the PANSS items, not a complete set of structural brain patterns identified in SZ 
and BD could be projected into either of the groups. 
There is limited power in the final polygenic risk score analysis. As described in the 
demographic information, the number of participants with available genetics and images was 
reduced compared to the full sample size in genetic risk score calculations. Especially in the BD 
group, with moderate effect size (0.5 for t-test), α level at 0.05, the minimal total sample size to 
achieve power over 95% (assuming equal sample size in each group) is 210 (105 for each group) 
(Faul, Erdfelder, Lang, & Buchner, 2007). Our sample size for BD was slightly above this power 
requirement. However, in the actual practice of imaging genetic studies, a moderate effect size is 
not common (Hashimoto et al., 2015; Jiang et al., 2019), though a previous power model of 
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imaging genetics was suggested based on a moderate effect size of 0.5 (Carter et al., 2017). In 
the situation with these data (setting effect size to be small, effect size = 0.2, α level at 0.05, and 
power = 0.95), the minimal total sample size would be 1188 (594 subjects for each group), in 
which case these analyses are definitely underpowered. In addition, we were not able to use the 
original genetic data from the TOP dataset which had identified the correlated brain patterns and 
symptom profiles. We had to project the brain patterns into B-SNIP samples, which provided 
genetic and imaging data. During the projection process, there could be a risk of losing dataset-
specific variations and the nonexistence of such components in the target data (Chen et al., 2019). 
Though we tried an independent ICA to extract a similar apathy component, this subtle 
relationship added to the difficulty of revealing the genetic mechanism behind apathy. 
5.6 Conclusions and future directions  
This work indicated shared structural brain alterations in frontal-temporal-parietal circuits 
behind distinct symptom profiles (positive, mood, and apathy) in the SZ and BD populations 
through multivariate analysis. Additionally, we found shared polygenic risks of SZ and BD were 
affecting the structural brain alterations. Despite the differences in symptom profiles, extracted 
brain patterns fell within the frontal-temporal-parietal network while emphasizing the critical 
temporal regions, including inferior, middle, and superior temporal gyrus. Importantly, they were 
explained by compared polygenic risk regardless of the original diagnoses. These results raised 
essential research questions for future studies.   
Firstly, at the clinical observation level, it is critical to include more broad but symptom 
domain balanced assessment tools. In the current analysis, we used PANSS as it is a valuable 
tool in detecting the psychiatric symptoms across diagnoses.  However, PANSS didn’t cover all 
the symptoms commonly observed clinically, and the scores for each of symptom domains were 
69 
not perfectly balanced. For instance, limited information is covered the single item of depression, 
and hidden information of depression can also be observed in more subtle behavioral changes. 
One choice is to include a wide selection of current clinical assessment scales, though it was 
difficult to keep so many scales consistently rated across different sites. Along with the enlarged 
inter-rater bias, the different scoring scales, inner structures, and factors in various tools would 
be hard to control in future data analyses  (Pearlson et al., 2016). Imaging genetic and 
multivariate methods compatible symptom scales are needed to provide clinical profiles covering 
the whole symptom domains without current diagnostic specificity. In addition, it would need to  
be easy to use for reducing inter-rater bias, or it can be built as a self-report tool for large data 
collection. The items would be easy to read without ambiguity, and the different levels of scores 
would easily be distinguished from each other. The Symptom Checklist-90 (SCL-90) and the 
revised version might be a potentially useful choice (Derogatis & Cleary, 1977; Jiang et al., 2019; 
Schmitz et al., 2000). Each question or item in SCL-90 is straightforward for the rater to 
understand, and it covers the symptom details we would like to collect from the patients.  
Secondly, more brain measures than simply gray matter, and explicitly cross-diagnostic 
analytic tools would be helpful. Interestingly, within the framework of multivariate analysis, 
novel methods as parallel group ICA and multi-site canonical correlation analysis with 
reference + joint ICA (MCCAR + jICA) were developed to help achieve these goals. They would 
be helpful in incorporating multiple modalities in imaging data, e.g. gray matter and white matter 
together, guided by single scale score or the full input of item scores of a specific scales (Qi et al., 
2020; Qi et al., 2019; Sui et al., 2018). These more recent approaches have the benefit of being 
tolerant to missing data, which hampered the pICA analyses. Regarding the clinical data 
availability across sites and the different scales of the assessment data, these methods could 
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avoid the current problem while projecting the data. Due to the small effect sizes of common 
variations and the difficulty in separating disorder-specific SNPs from the rest of the whole 
genome, sparse parallel ICA was designed recently to improve genomic data's results (Duan et 
al., 2020).  This could provide another reliable and possibly more sensitive way of exploring 
genetic effects on the brain and behavioral data. 
Another future direction would be constructing PRS based on genetic pathways, more 
detailed phenotype information, and genetic factors closely connected to structural brains 
(Toulopoulou et al., 2019). For complicated human diseases, including psychotic disorders, PRS 
may have independent effects on behavioral, environmental, and clinical risk factors such as 
lifestyle and stressful life events (Janssens, 2019; Musliner et al., 2015). In measuring the exact 
effects of PRS on intermediate phenotypes as brain structures, we may need to rule out the above 
independent effects of PRS (Konigorski, Wang, Cigsar, & Yilmaz, 2018). Constructing PRS 
based on variations involved in the pathways or gene sets (e.g., abnormal long-term potentiation 
or electrophysiology) directly affecting brain development, morphometry, and function out of the 
total PRS is one potential direction (Grama et al., 2020). Another choice is collecting variations 
involved in certain clinical domains that are directly associated with brains, such as a specific 
field of cognitive functions or symptom profiles (Toulopoulou et al., 2019). It helps elucidate the 
functional implication and restrict the genetic effect compared with total PRS effects 
simultaneously. In current work, we were estimating the PRS based on diagnostic phenotypes, 
and we were following the idea that specific psychotic disorder risks were the source of 
modifying the brains. Future work would need to collect brain structures related to genetic risks 
while stepping out of current diagnoses' categories (Carter et al., 2017). By doing so, stronger 
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